Share This Page
Drug Price Trends for FT MUCUS RELIEF D ER
✉ Email this page to a colleague

Average Pharmacy Cost for FT MUCUS RELIEF D ER
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
FT MUCUS RELIEF D ER 600-60 MG | 70677-1011-01 | 0.32758 | EACH | 2025-03-19 |
FT MUCUS RELIEF D ER 600-60 MG | 70677-1011-01 | 0.34247 | EACH | 2025-02-19 |
FT MUCUS RELIEF D ER 600-60 MG | 70677-1011-01 | 0.34175 | EACH | 2025-01-22 |
FT MUCUS RELIEF D ER 600-60 MG | 70677-1011-01 | 0.34760 | EACH | 2024-12-18 |
FT MUCUS RELIEF D ER 600-60 MG | 70677-1011-01 | 0.34559 | EACH | 2024-11-20 |
FT MUCUS RELIEF D ER 600-60 MG | 70677-1011-01 | 0.34040 | EACH | 2024-10-23 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for FT MUCUS RELIEF D ER
Introduction to Guaifenesin and FT MUCUS RELIEF D ER
Guaifenesin, the active ingredient in FT MUCUS RELIEF D ER, is an expectorant used to thin mucus in the air passages, making it easier to cough up. This medication is commonly used to treat cough, nasal congestion, and other respiratory issues.
Global Guaifenesin Market Overview
The global guaifenesin market is projected to grow significantly over the next few years. Here are some key points:
- Market Size and Growth: The global guaifenesin market is forecasted to reach USD 95 million by 2027, growing at a Compound Annual Growth Rate (CAGR) of around 3.1% from 2022 to 2027[1][4].
- Applications: The primary application of guaifenesin is in cough treatment drugs, which is the fastest-growing segment, expected to grow with a CAGR of around 3.7% during the forecast period[1].
FT MUCUS RELIEF D ER: Product Details
FT MUCUS RELIEF D ER is a combination drug that includes guaifenesin and pseudoephedrine. Here are some key details:
- Composition: It contains 600 mg of guaifenesin and 60 mg of pseudoephedrine per extended-release tablet[2].
- Usage: It is used for treating cough and nasal congestion, making it a popular choice for upper respiratory issues[2].
Price Projections and Market Trends
Current Pricing
The cost for FT MUCUS RELIEF D ER (600 mg-60 mg) oral tablet, extended release, is around $11 for a supply of 18 tablets, depending on the pharmacy and any discounts applied[2].
Price Variability
Prices can vary based on the pharmacy and availability. Here is a breakdown of the pricing:
- Quantity and Price: For 18 tablets, the price is approximately $11.08, which translates to $0.62 per unit[2].
Discounts and Assistance Programs
- Discount Cards: The Drugs.com Discount Card can save consumers up to 80% or more off the cost of the medication[2][5].
- Patient Assistance Programs: While there are no specific patient assistance programs for FT MUCUS RELIEF D ER, healthcare providers may have information on other available programs[2][5].
Market Drivers
Several factors are driving the growth of the guaifenesin market, including:
- Increasing Respiratory Issues: The rising cases of respiratory complications such as cough, chest congestion, and acute rhinosinusitis are creating a significant demand for guaifenesin-based medications[1].
- Advancements in Pharmaceutical Sector: Robust advancements in hospital infrastructure and innovations in drug delivery and processing projects are boosting the growth prospects for guaifenesin[1].
- Growing Pharmaceutical Market: The Indian pharmaceutical sector, for example, is expected to reach USD 65 billion by 2024 and around USD 120-130 billion by 2030, further driving the demand for guaifenesin[1].
Market Challenges
Despite the growth, the guaifenesin market faces some challenges:
- Availability of Substitutes: The presence of substitute medications can pose a challenge to the market growth of guaifenesin[1].
- Potential Side Effects: Guaifenesin, like any medication, can have side effects, which may deter some consumers and affect market growth[1].
Geographical Market Analysis
The guaifenesin market is segmented geographically into several regions:
- North America: Includes the USA, Canada, and Mexico.
- Europe: Includes the UK, Germany, France, Italy, and others.
- Asia-Pacific: Includes China, Japan, India, South Korea, and others.
- South America: Includes Brazil, Argentina, Colombia, and others.
- Middle East and Africa: Includes Saudi Arabia, UAE, Israel, South Africa, and others[1].
Each region has its own set of market dynamics and growth prospects, with the Asia-Pacific region showing significant potential due to the large population and growing healthcare sector.
Recent Developments
Several recent developments highlight the ongoing activity in the guaifenesin market:
- Approval of New Products: Companies like Granules India and Aurobindo Pharma have received approvals for extended-release guaifenesin tablets, expanding the product portfolio in the market[1].
- Launch of New Products: Dr. Reddy's Laboratories Limited launched an OTC store-brand equivalent of Mucinex D extended release tablet, which includes guaifenesin and pseudoephedrine, further boosting the market[1].
Key Takeaways
- The global guaifenesin market is expected to reach USD 95 million by 2027, growing at a CAGR of 3.1%.
- The cough treatment drug segment is the fastest-growing, with a CAGR of around 3.7%.
- FT MUCUS RELIEF D ER is priced around $11 for 18 tablets, with potential discounts through discount cards.
- The market is driven by increasing respiratory issues and advancements in the pharmaceutical sector.
- Challenges include the availability of substitutes and potential side effects.
FAQs
1. What is the primary use of guaifenesin in medications? Guaifenesin is used as an expectorant to thin mucus in the air passages, making it easier to cough up.
2. What is the projected market size of the global guaifenesin market by 2027? The global guaifenesin market is forecasted to reach USD 95 million by 2027[1][4].
3. How much does FT MUCUS RELIEF D ER typically cost? The cost for FT MUCUS RELIEF D ER (600 mg-60 mg) oral tablet, extended release, is around $11 for a supply of 18 tablets[2].
4. What are the main drivers of the guaifenesin market growth? The main drivers include increasing respiratory issues, advancements in the pharmaceutical sector, and growing demand in hospitals and clinics[1].
5. Are there any patient assistance programs available for FT MUCUS RELIEF D ER? No specific patient assistance programs are available for FT MUCUS RELIEF D ER, but healthcare providers may have information on other available programs[2][5].
Sources
- IndustryARC: Guaifenesin Market Size Report, 2022-2027.
- Drugs.com: Mucus Relief D Prices, Coupons, Copay Cards & Patient Assistance.
- Mordor Intelligence: Expectorant Drugs Market Size & Share Analysis.
- DrugPatentWatch: Drug prices and trends for QC MUCUS RELIEF ER.
- Drugs.com: Mucus Relief DM Prices, Coupons, Copay Cards & Patient Assistance.
More… ↓